USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Cold chain Investments and Hybrid Clinical Trials to Ensure Transformational Growth of Pharmaceutical Logistics
30-Dec-2022
Global
Market Research
MG72-01-00-00-00
HC03630-GL-MT_27380
Medicine production supply chains are currently operating under huge stress due to the war in Ukraine, COVID-19-related disruptions, logistics bottlenecks, and inflation. An energy-related shutdown of production would have a detrimental effect on the supply of critical medicines to patients in the EU and worldwide. The excessive amount of pressure on healthcare supply chains worldwide is driving companies to address vulnerabilities.
Pharmaceutical companies will need to rely heavily on an unprecedented level of cooperation from raw material suppliers, government agencies, and contract development and manufacturing organizations.
The increasing focus on biologics, adoption of technology, and shift to patient-centric model is transforming the pharma logistics market; the COVID-19 pandemic has sped up the rate of transformation and acted as a catalyst for the adoption of decentralized trials. This has increased the complexity of coordination of not only clinical trial supply management but also healthcare professionals, and arranging necessary infrastructure for drug storage and infusion.
This research analytics on the global pharmaceutical logistics market identifies some of the leading growth opportunity areas in cold chain capabilities for next-generation vaccines and biologics and hybrid trial logistics ensuring patient enrollment and diversity, highlighting the improved last-mile connectivity to propagate the anytime-anywhere care business model. In addition, the market is witnessing the simultaneous adoption of predictive supply chain solutions that optimize pharma operations and improve profitability.
Author: Unmesh Lal
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Pharmaceutical Logistics Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Scope of Analysis
Segmentation
Market Dynamics
Market Dynamics (continued)
Value Chain Analysis
Key Competitors
Vendor Landscape
Growth Drivers for Pharmaceutical Logistics
Growth Restraints for Pharmaceutical Logistics
Regional Analysis—North America (NA)
Regional Analysis—Europe
Regional Analysis—United Kingdom (UK)
Regional Analysis—Asia-Pacific (APAC)
Contract-logistics-provider-related Developments
Contract-logistics-provider-related Developments (continued)
Supply-chain-solution-provider-related Developments
Supply-chain-solution-provider-related Developments (continued)
CDMO-r
CDMO-r (continued)
CRO-related Developments
CRO-related Developments (continued)
Pharma LogisticsPrimed for Business Model Disruption
Growth Opportunity Universe—A Summary
Growth Opportunity Universe Summary
Growth Opportunity 1: Repurposing Cold Chain Capabilities
Growth Opportunity 1: Repurposing Cold Chain Capabilities (continued)
Global Cold-Chain Products Sales
Global Cold-Chain Products Sales (continued)
Global Cold-Chain Logistics Spending
Global Cold-Chain Logistics Spending
Growth Opportunity 2: Hybrid Trial Logistics
Growth Opportunity 2: Hybrid Trial Logistics (continued)
Case Study—DHL
Case Study—Marken (UPS)
Growth Opportunity 3: Improved Last-mile Connectivity
Growth Opportunity 3: Improved Last-mile Connectivity (continued)
eCommerce—Disrupting the Traditional Supply Chain Model
Case Study—Capsule
Growth Opportunity 4: Predictive Supply Chain
Growth Opportunity 4: Predictive Supply Chain (continued)
Case Study—Trek Therapeutics Uses Ambrosus’ Blockchain Solution for Quality Control
Case Study—Macro-Eyes’ ML Solutions Bring Predictability to the Vaccine Supply Chain
Companies to Action
List of Exhibits
Legal Disclaimer
List of Figures
- Pharmaceutical Logistics: Growth Drivers, Global, 2022–2026
- Pharmaceutical Logistics: Growth Restraints, Global, 2022–2026
- Global Biopharma Sales Forecast, 2018–2024
- Global Biopharma Logistics Spending, 2018–2024
- Supply Chain and Packaging: Anytime-Anywhere Care Model, Global, 2022
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| Author | Unmesh Lal |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| List of Charts and Figures | Pharmaceutical Logistics: Growth Drivers, Global, 2022–2026~ Pharmaceutical Logistics: Growth Restraints, Global, 2022–2026~ Global Biopharma Sales Forecast, 2018–2024~ Global Biopharma Logistics Spending, 2018–2024~ Supply Chain and Packaging: Anytime-Anywhere Care Model, Global, 2022~ |
| Podcast | No |
| WIP Number | MG72-01-00-00-00 |
Growth Opportunities in Global Pharmaceutical Logistics
$2,450.00
Special Price $1,837.50 save 25 %